REPORT ID 2769

EMEA (Europe, Middle East and Africa) Seasonal Influenza Vaccine Market Report 2017

Publish Date
11-Dec-17
Pages
115
Format
Electronic (PDF)

In this report, the EMEA Seasonal Influenza Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Doses), revenue (Million USD), market share and growth rate of Seasonal Influenza Vaccine for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Seasonal Influenza Vaccine market competition by top manufacturers/players, with Seasonal Influenza Vaccine sales volume (K Doses), price (USD/Dose), revenue (Million USD) and market share for each manufacturer/player; the top players including
    GSK
    Sinovac
    Changsheng
    CCBIO
    Aleph Biomedical
    Sanofi
    Lanzhou Institute Of Biological Product
    Siobp
    Hualan Bio
    Tianyuan Bio-Pharma
    Vaxtec
    Hissen
    Abbott
    Novartis
    Tasly&Jenner
    Tiantan

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Trivalent Influenza Vaccine
    Quadrivalent Influenza Vaccine
    Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Children
    Adults
    Elderly
    Pregnancy

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Seasonal Influenza Vaccine Market Report 2017
1 Seasonal Influenza Vaccine Overview
    1.1 Product Overview and Scope of Seasonal Influenza Vaccine
    1.2 Classification of Seasonal Influenza Vaccine
        1.2.1 EMEA Seasonal Influenza Vaccine Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Seasonal Influenza Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Trivalent Influenza Vaccine
        1.2.4 Quadrivalent Influenza Vaccine
        1.2.5 Other
    1.3 EMEA Seasonal Influenza Vaccine Market by Application/End Users
        1.3.1 EMEA Seasonal Influenza Vaccine Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Children
        1.3.3 Adults
        1.3.4 Elderly
        1.3.5 Pregnancy
    1.4 EMEA Seasonal Influenza Vaccine Market by Region
        1.4.1 EMEA Seasonal Influenza Vaccine Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Seasonal Influenza Vaccine (2012-2022)
        1.5.1 EMEA Seasonal Influenza Vaccine Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Seasonal Influenza Vaccine Revenue and Growth Rate (2012-2022)

2 EMEA Seasonal Influenza Vaccine Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Seasonal Influenza Vaccine Market Competition by Players/Manufacturers
        2.1.1 EMEA Seasonal Influenza Vaccine Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Seasonal Influenza Vaccine Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Seasonal Influenza Vaccine Sale Price by Players (2012-2017)
    2.2 EMEA Seasonal Influenza Vaccine (Volume and Value) by Type/Product Category
        2.2.1 EMEA Seasonal Influenza Vaccine Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Seasonal Influenza Vaccine Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Seasonal Influenza Vaccine Sale Price by Type (2012-2017)
    2.3 EMEA Seasonal Influenza Vaccine (Volume) by Application
    2.4 EMEA Seasonal Influenza Vaccine (Volume and Value) by Region
        2.4.1 EMEA Seasonal Influenza Vaccine Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Seasonal Influenza Vaccine Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Seasonal Influenza Vaccine Sales Price by Region (2012-2017)

3 Europe Seasonal Influenza Vaccine (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Seasonal Influenza Vaccine Sales and Value (2012-2017)
        3.1.1 Europe Seasonal Influenza Vaccine Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Seasonal Influenza Vaccine Revenue and Growth Rate (2012-2017)
    3.2 Europe Seasonal Influenza Vaccine Sales and Market Share by Type
    3.3 Europe Seasonal Influenza Vaccine Sales and Market Share by Application
    3.4 Europe Seasonal Influenza Vaccine Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Seasonal Influenza Vaccine Sales Volume by Countries (2012-2017)
        3.4.2 Europe Seasonal Influenza Vaccine Revenue by Countries (2012-2017)
        3.4.3 Germany Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
        3.4.4 France Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
        3.4.5 UK Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
        3.4.6 Russia Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
        3.4.7 Italy Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)

4 Middle East Seasonal Influenza Vaccine (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Seasonal Influenza Vaccine Sales and Value (2012-2017)
        4.1.1 Middle East Seasonal Influenza Vaccine Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Seasonal Influenza Vaccine Revenue and Growth Rate (2012-2017)
    4.2 Middle East Seasonal Influenza Vaccine Sales and Market Share by Type
    4.3 Middle East Seasonal Influenza Vaccine Sales and Market Share by Application
    4.4 Middle East Seasonal Influenza Vaccine Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Seasonal Influenza Vaccine Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Seasonal Influenza Vaccine Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
        4.4.4 Israel Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
        4.4.5 UAE Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
        4.4.6 Iran Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)

5 Africa Seasonal Influenza Vaccine (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Seasonal Influenza Vaccine Sales and Value (2012-2017)
        5.1.1 Africa Seasonal Influenza Vaccine Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Seasonal Influenza Vaccine Revenue and Growth Rate (2012-2017)
    5.2 Africa Seasonal Influenza Vaccine Sales and Market Share by Type
    5.3 Africa Seasonal Influenza Vaccine Sales and Market Share by Application
    5.4 Africa Seasonal Influenza Vaccine Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Seasonal Influenza Vaccine Sales Volume by Countries (2012-2017)
        5.4.2 Africa Seasonal Influenza Vaccine Revenue by Countries (2012-2017)
        5.4.3 South Africa Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)

6 EMEA Seasonal Influenza Vaccine Manufacturers/Players Profiles and Sales Data
    6.1 GSK
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Seasonal Influenza Vaccine Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 GSK Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Sinovac
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Seasonal Influenza Vaccine Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Sinovac Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Changsheng
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Seasonal Influenza Vaccine Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Changsheng Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 CCBIO
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Seasonal Influenza Vaccine Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 CCBIO Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Aleph Biomedical
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Seasonal Influenza Vaccine Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Aleph Biomedical Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Sanofi
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Seasonal Influenza Vaccine Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Sanofi Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Lanzhou Institute Of Biological Product
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Seasonal Influenza Vaccine Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Siobp
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Seasonal Influenza Vaccine Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Siobp Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Hualan Bio
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Seasonal Influenza Vaccine Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Hualan Bio Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Tianyuan Bio-Pharma
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Seasonal Influenza Vaccine Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Tianyuan Bio-Pharma Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Vaxtec
    6.12 Hissen
    6.13 Abbott
    6.14 Novartis
    6.15 Tasly&Jenner
    6.16 Tiantan

7 Seasonal Influenza Vaccine Manufacturing Cost Analysis
    7.1 Seasonal Influenza Vaccine Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Seasonal Influenza Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Seasonal Influenza Vaccine Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Seasonal Influenza Vaccine Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Seasonal Influenza Vaccine Market Forecast (2017-2022)
    11.1 EMEA Seasonal Influenza Vaccine Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Seasonal Influenza Vaccine Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Seasonal Influenza Vaccine Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Seasonal Influenza Vaccine Price and Trend Forecast (2017-2022)
    11.2 EMEA Seasonal Influenza Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Seasonal Influenza Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Seasonal Influenza Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Seasonal Influenza Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Seasonal Influenza Vaccine Sales Forecast by Type (2017-2022)
    11.7 EMEA Seasonal Influenza Vaccine Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer